AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
Ivashchenko et al., Clinical Infectious Diseases, doi:10.1093/cid/ciaa1176
https://c19early.org/ivashchenko.html